Cardiovascular and Renal Drugs Advisory Committee Meeting
April 18, 2007
Slides
Sponsor Presentation
Bristol-Myers Squibb (ppt) (htm)
Open Public Hearing Presentation
The Rationale for Initiating Therapy with Fixed-Dose Combinations in Hypertension, Thomas D. Giles, M.D., Tulane University School of Medicine, New Orleans (On behalf of Novartis Pharmaceuticals) (ppt) (htm)
Up
| AC Home Page